Law firms trolling for unhappy Icagen investors; gIcare Pharma raises $7M; ReNeuron shakes up board

@FierceBiotech: Biogen Idec abandoning Weston, plots move to Kendall Sq. News | Follow @FierceBiotech

@JohnCFierce: If this Medco takeover goes through, I have to wonder how many jobs will be cut. Article | Follow @JohnCFierce

> Pfizer's $6-a-share buyout deal for Icagen has attracted the attention of a number of law firms now chumming the waters for unhappy investors. After word spread of a possible buyout, investors quickly drove up the value of Icagen's stock, only to watch the share price plunge 23% yesterday after Pfizer made off with the company--a longtime partner--at a much lower price than expected. Now the AP reports that at least 5 firms are exploring if investors are willing to sign up for a lawsuit. Story

> Canada's gIcare Pharma says it raised $7 million in a Series A round. Release

> Manhattan Pharmaceuticals says it reached an agreement with the FDA on a special protocol assessment for a Phase III clinical trial of AST-726 in patients with a medical history of vitamin B12 deficiency. Release

> Scotland's ReNeuron is shaking up its board of directors after Chairman Trevor Howard announced plans to step down and form a new advisory group. Article

Pharma News

@FiercePharma: In this week's Sermo survey, almost 50% of MDs say they won't switch patients from Pradaxa. Item | Follow @FiercePharma

> Express Scripts strikes $29B deal for Medco. Report

> Roche, Lilly profits drop as Abbott sales grow. More

> Pfizer waxes philosophical about Facebook hack. Article

> Study: MS drugs' benefits carry a steep price. News

Manufacturing News

> Hamied of Cipla honored in U.K., protests Western patent tactics. Article

> Sun exec, Generic firms will face the same tough times as innovators. Item

> FDA grants aids manufacturing, regulatory science. News

> Fool's manufacturing view akin to Witty's of GSK. More

> GSK, Lundbeck reveal lean secrets, successes. Story

> Silicone particles drive American Regent recall. Report

Vaccine News

> Astellas licenses Vical vax for $130M. Article

> NicVAX failure spells trouble for Nabi. More

> Scripps explores heroin addiction vaccine. Story

> WHO: Flu vaccine production will double by 2015. Report

And Finally... A new study has found that the taller a woman is, the greater are her chances of getting cancer. Story

Suggested Articles

All 12 members of an FDA advisory committee voted to recommend the approval of teprotumumab for a rare, autoimmune eye disease.

Early data out of former Fierce 15 winner Gritstone Oncology have been heralded as a big win for the early-stage biotech by analysts.

Biogen will drop work on gosuranemab in progressive supranuclear palsy but continue on in Alzheimer's.